Publications by authors named "R Di Lauro"

The ADP-ribosyl hydrolases PARG and ARH3 counteract PARP enzymatic activity by removing ADP-ribosylation. PARG and ARH3 activities have a synthetic lethal effect; however, the specific molecular mechanisms underlying this response remain unknown. Here, we show that the PARG and ARH3 synthetic lethality is enhanced further in the presence of DNA alkylating agents, suggesting that the inability to revert ADP-ribosylation primarily affects the repair of alkylated DNA bases.

View Article and Find Full Text PDF

Cardiac involvement strongly impacts prognosis in patients with Anderson-Fabry disease (AFD). All cardiac structures, such as the left ventricle and the left atrium, the aorta, the right sections, and the heart valves can be affected by morphological and functional abnormalities. Standard echocardiography has a crucial role in the characterization of AFD cardiomyopathy.

View Article and Find Full Text PDF

Hypovolemic shock is a circulatory failure, due to a loss in the effective circulating blood volume, that causes tissue hypoperfusion and hypoxia. This condition stimulates reactive oxygen species (ROS) and pro-inflammatory cytokine production in different organs and also in the central nervous system (CNS). Levosimendan, a cardioprotective inodilator, and dobutamine, a β1-adrenergic agonist, are commonly used for the treatment of hypovolemic shock, thanks to their anti-inflammatory and antioxidant effects.

View Article and Find Full Text PDF
Article Synopsis
  • Systemic sclerosis (SSc) is a rare disease that can affect different parts of the body and can be very serious, especially affecting the lungs and heart.
  • New research has found new treatments for SSc-related lung disease, and recent clinical trials have studied how well these treatments work.
  • The most common medicines for treating this lung issue in SSc are cyclophosphamide and mycophenolate mofetil, while other drugs like nintedanib and tocilizumab can help slow down problems with breathing.
View Article and Find Full Text PDF
Article Synopsis
  • Type 2 Diabetes Mellitus (T2D) is a widespread chronic disease, and its causes remain largely unclear, but oxidative stress is believed to play a significant role in its development.
  • Oxidative stress can lead to insulin resistance and pancreatic issues, as well as increase the risk of cardiovascular disease (CVD), making it crucial to explore the connections between these factors.
  • The discussion includes how understanding oxidative stress could enhance treatment strategies for T2D and potentially leverage existing hypoglycemic therapies as antioxidant agents to help prevent CVD in affected patients.
View Article and Find Full Text PDF